| Copper | Approved Investigational | CHD2 | 1106 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CHD2 mRNA | 15q26.1 | |
| Copper | Approved Investigational | CHDH | 55349 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CHDH mRNA | 3p21.1 | |
| Copper | Approved Investigational | CHEK1 | 1111 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CHEK1 mRNA | 11q24.2 | |
| Copper | Approved Investigational | CHGA | 1113 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CHGA mRNA | 14q32.12 | |
| Copper | Approved Investigational | CHIC1 | 53344 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CHIC1 mRNA | Xq13.2 | |
| Copper | Approved Investigational | CHIC2 | 26511 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CHIC2 mRNA | 4q12 | |
| Copper | Approved Investigational | CHM | 1121 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CHM mRNA | Xq21.2 | |
| Copper | Approved Investigational | CHMP1B | 57132 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CHMP1B mRNA | 18p11.21 | |
| Copper | Approved Investigational | CHN1 | 1123 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CHN1 mRNA | 2q31.1 | |
| Copper | Approved Investigational | CHORDC1 | 26973 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA | 11q14.3 | |
| Copper | Approved Investigational | CHRNA5 | 1138 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CHRNA5 mRNA | 15q25.1 | |
| Copper | Approved Investigational | CIDECP | 152302 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CIDECP mRNA | 3p25.3 | |
| Copper | Approved Investigational | CILP | 8483 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CILP mRNA | 15q22.31 | |
| Copper | Approved Investigational | CIRBP | 1153 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CIRBP mRNA | 19p13.3 | |
| Copper | Approved Investigational | CISD3 | 284106 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CISD3 mRNA | 17q12 | |
| Copper | Approved Investigational | CIT | 11113 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CIT mRNA | 12q24.23 | |
| Copper | Approved Investigational | CKAP4 | 10970 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CKAP4 mRNA | 12q23.3 | |
| Copper | Approved Investigational | CLCN4 | 1183 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLCN4 mRNA | Xp22.2 | |
| Copper | Approved Investigational | CLDN1 | 9076 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CLDN1 mRNA | 3q28 | |
| Copper | Approved Investigational | CLDN1 | 9076 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLDN1 mRNA | 3q28 | |
| Copper | Approved Investigational | CLDN11 | 5010 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CLDN11 mRNA | 3q26.2 | |
| Copper | Approved Investigational | CLDN12 | 9069 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLDN12 mRNA | 7q21.13 | |
| Copper | Approved Investigational | CLDN15 | 24146 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLDN15 mRNA | 7q22.1 | |
| Copper | Approved Investigational | CLDN3 | 1365 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CLDN3 mRNA | 7q11.23 | |
| Copper | Approved Investigational | CLDND1 | 56650 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CLDND1 mRNA | 3q11.2 | |